Implications of drug-resistant Streptococcus pneumoniae for otitis media

Pediatric Infectious Disease Journal

Volumn 17, Issue 10, 1998, Pages 953-956

  Poole, Michael D ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Antibiotic resistance; Microbiology; Otitis media; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFACLOR; CEFIXIME; CEFPODOXIME PROXETIL; CEFPROZIL; CEFTIBUTEN; CEFUROXIME AXETIL; CIPROFLOXACIN; CLARITHROMYCIN; LORACARBEF; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; CHRONIC OTITIS MEDIA; CONFERENCE PAPER; DRUG EFFICACY; GEOGRAPHIC DISTRIBUTION; HAEMOPHILUS INFLUENZAE; HIGH RISK POPULATION; HUMAN; INFECTION RISK; MINIMUM INHIBITORY CONCENTRATION; MYRINGOTOMY; ORAL DRUG ADMINISTRATION; OTITIS MEDIA; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; STREPTOCOCCUS PNEUMONIAE;

CHILD; DRUG RESISTANCE, MICROBIAL; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 0031792572     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199810000-00039     Document Type: Conference Paper

References (16)

1. Schwartz B. Surveillance data presented at the Centers for Disease Control Therapeutic Working Group on Drug Resistant Streptococcus pneumoniae in Otitis Media, Atlanta, GA, March 20 to 21, 1997.
2. Doern GV. Trends in antimicrobial susceptibility of bacterial pathogens from the respiratory tract. Am J Med 1995;99(Suppl 6B):3S-7S.
3. Del Castillo F, Baquero-Artigao F, Garcia-Perea A. Influence of recent antibiotic therapy on antimicrobial resistance of Streptococcus pneumoniae in children with acute otitis in Spain. Pediatr Infect Dis J 1998;17:94-7.
4. Harrison CJ, Belhorn TH. Antibiotic treatment failures in acute otitis media. Pediatr Ann 1991;20:600-1.
5. Marchant CD, Carlin SA, Johnson CE, Shurin PA. Measuring the comparative efficacy of antibacterial agents for acute otitis media: the "Pollyanna phenomenon." J Pediatr 1992;120:72-7.
6. Craig WA. Antimicrobial resistance issues of the future. Diagn Microbiol Infect Dis 1996;25:213-7.
7. Dagan R, Piglansky L, Yagupsky P, Fliss DM, Lieberman A, Leibovitz E. Bacteriologic response in acute otitis media: comparison between azithromycin, cefaclor, and amoxicillin. Poster presented at the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, September 28 to October 4, 1997.
8. Dagan R, Abramson O, Leibovitz E, Lang R, et al. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. Pediatr Infect Dis J 1996;15:980-5.
9. Dagan R. Data presented at the Centers for Disease Control Therapeutic Working Group on Drug Resistant Streptococcus pneumoniae in Otitis Media, Atlanta, GA, March 2:0 to 21, 1997.
10. Howie VM, Dillard R, Lawrence B. In vivo sensitivity test in otitis media: efficacy of antibiotics. Pediatrics 1985;75:8-13.
11. Dowell S (Chairman). Meeting of Centers for Disease Control Therapeutic Working Group on Drug Resistant Streptococcus pneumoniae in Otitis Media, Atlanta, GA, March 20 to 21, 1997.
12. Jackson MA, Burry VF, Olsen LC, Duthie SE, Kearns GL. Breakthrough sepsis in macrolide-resistant pneumococcal infection. Pediatric Infect Dis J 1996;15:1049-51.
13. Drusano GL, Craig WA. Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections. J Chemother 1997;3:38-44.
14. Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J. 1996;15:255-9.
15. Bottenfield GW, Burch DJ, Hedrick JA, Schaten R, Rowinski C, Davies JT. Safety and tolerability of a new formulation(90 mg/kg/day divided q12) of amoxicillin/clavulanate (Augmentin) in the empiric treatment of pediatic acute otitis media due to drug-resistant Streptococcus pneumoniae.
16. Centers for Disease Control. Morbidity and Mortality Weekly Report. January 14, 1994.